These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23108396)

  • 1. H2A.Z-dependent crosstalk between enhancer and promoter regulates cyclin D1 expression.
    Dalvai M; Bellucci L; Fleury L; Lavigne AC; Moutahir F; Bystricky K
    Oncogene; 2013 Sep; 32(36):4243-51. PubMed ID: 23108396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIP48/Reptin and H2A.Z requirement for initiating chromatin remodeling in estrogen-activated transcription.
    Dalvai M; Fleury L; Bellucci L; Kocanova S; Bystricky K
    PLoS Genet; 2013 Apr; 9(4):e1003387. PubMed ID: 23637611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-dependent transcriptional control in L6 rat myotubes is associated with modulation of histone acetylation and accumulation of the histone variant H2A.Z in the proximity of the transcriptional start site.
    Zerzaihi O; Chriett S; Vidal H; Pirola L
    Biochem Cell Biol; 2014 Feb; 92(1):61-7. PubMed ID: 24471919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p21 transcription is regulated by differential localization of histone H2A.Z.
    Gévry N; Chan HM; Laflamme L; Livingston DM; Gaudreau L
    Genes Dev; 2007 Aug; 21(15):1869-81. PubMed ID: 17671089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JAZF1, A Novel p400/TIP60/NuA4 Complex Member, Regulates H2A.Z Acetylation at Regulatory Regions.
    Procida T; Friedrich T; Jack APM; Peritore M; Bönisch C; Eberl HC; Daus N; Kletenkov K; Nist A; Stiewe T; Borggrefe T; Mann M; Bartkuhn M; Hake SB
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Myc-induced histone modifications on target chromatin.
    Martinato F; Cesaroni M; Amati B; Guccione E
    PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.
    Bellucci L; Dalvai M; Kocanova S; Moutahir F; Bystricky K
    PLoS One; 2013; 8(1):e54102. PubMed ID: 23349794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAF1 histone acetyltransferase activity in Sp1 activation of the cyclin D1 promoter.
    Hilton TL; Li Y; Dunphy EL; Wang EH
    Mol Cell Biol; 2005 May; 25(10):4321-32. PubMed ID: 15870300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer.
    Valdés-Mora F; Song JZ; Statham AL; Strbenac D; Robinson MD; Nair SS; Patterson KI; Tremethick DJ; Stirzaker C; Clark SJ
    Genome Res; 2012 Feb; 22(2):307-21. PubMed ID: 21788347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin.
    Ding J; Yu C; Sui Y; Wang L; Yang Y; Wang F; Yao H; Xing F; Liu H; Li Y; Shah JA; Cai Y; Jin J
    FEBS J; 2018 Sep; 285(17):3270-3285. PubMed ID: 30055111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histone variant H2A.Z is an important regulator of enhancer activity.
    Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
    Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3 lysine 4 trimethylation regulates cotranscriptional H2A variant exchange by Tip60 complexes to maximize gene expression.
    Kusch T; Mei A; Nguyen C
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4850-5. PubMed ID: 24639513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer.
    Hsu CC; Shi J; Yuan C; Zhao D; Jiang S; Lyu J; Wang X; Li H; Wen H; Li W; Shi X
    Genes Dev; 2018 Jan; 32(1):58-69. PubMed ID: 29437725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional induction of the osteocalcin gene during osteoblast differentiation involves acetylation of histones h3 and h4.
    Shen J; Hovhannisyan H; Lian JB; Montecino MA; Stein GS; Stein JL; Van Wijnen AJ
    Mol Endocrinol; 2003 Apr; 17(4):743-56. PubMed ID: 12554783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3.3 actively marks enhancers and primes gene transcription via opening higher-ordered chromatin.
    Chen P; Zhao J; Wang Y; Wang M; Long H; Liang D; Huang L; Wen Z; Li W; Li X; Feng H; Zhao H; Zhu P; Li M; Wang QF; Li G
    Genes Dev; 2013 Oct; 27(19):2109-24. PubMed ID: 24065740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles for H4 and H2A.Z acetylation in RNA transcription in African trypanosomes.
    Kraus AJ; Vanselow JT; Lamer S; Brink BG; Schlosser A; Siegel TN
    Nat Commun; 2020 Mar; 11(1):1498. PubMed ID: 32198348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
    Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
    Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation.
    Janas JA; Zhang L; Luu JH; Demeter J; Meng L; Marro SG; Mall M; Mooney NA; Schaukowitch K; Ng YH; Yang N; Huang Y; Neumayer G; Gozani O; Elias JE; Jackson PK; Wernig M
    Mol Cell; 2022 Dec; 82(24):4627-4646.e14. PubMed ID: 36417913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomeric heterochromatin boundaries require NuA4-dependent acetylation of histone variant H2A.Z in Saccharomyces cerevisiae.
    Babiarz JE; Halley JE; Rine J
    Genes Dev; 2006 Mar; 20(6):700-10. PubMed ID: 16543222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
    Valdés-Mora F; Gould CM; Colino-Sanguino Y; Qu W; Song JZ; Taylor KM; Buske FA; Statham AL; Nair SS; Armstrong NJ; Kench JG; Lee KML; Horvath LG; Qiu M; Ilinykh A; Yeo-Teh NS; Gallego-Ortega D; Stirzaker C; Clark SJ
    Nat Commun; 2017 Nov; 8(1):1346. PubMed ID: 29116202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.